COALITION FOR LIFESAVING EMERGENCY ACCESS & RESPONSIBILITY

WHO WE ARE

The Coalition for Lifesaving Emergency Access & Responsibility (CLEAR) was founded by Robert Houton, whose child has a life-threatening peanut allergy. Our mission is simple: to expand access to, and awareness of, lifesaving emergency medicines and training for the public.

Whether a child, teen, or adult suffers an anaphylactic attack or requires emergency medical assistance in a stadium, on a cruise ship, in a restaurant, at an amusement park, or other frequently populated venue, CLEAR is working with first responders, associations, stakeholders, and elected officials to increase access to lifesaving medicines which save lives!

CLEAR® SAVES LIVES. YOU CAN TOO.

JOIN THE MISSION

Through joining CLEAR as an Individual Member, you will be supporting CLEAR’s critically needed advocacy activities and be invited to participate in exciting events with other members throughout 2020.

Ready to help save lives?

BECOME AN INDIVIDUAL MEMBER

“$30 FOR 30”

In joining the Coalition for Lifesaving Emergency Access & Responsibility (CLEAR) as an Individual Member, your $30 matches CLEAR’s mission to save lives.

As the World Allergy Council states an anaphylactic attack commonly peaks within 30 minutes so in becoming a CLEAR Individual Member, you are helping CLEAR in our mission to save lives and prevent deaths from anaphylaxis through our efforts to expand access to lifesaving medicines for the public!

The benefits you receive in your CLEAR Membership include invitations to participate in CLEAR Member-Only events, receptions, advocacy days in Washington D.C., and frequent communications through our website and APP on successes CLEAR is leading in the U.S. to expand access to epinephrine devices, and other urgently needed medicines and emergency services.

  • $0.00
  • American Express
    Discover
    MasterCard
    Visa
     

OUR STORY

Recognized by national media including CNN, Forbes, the Boston Globe, The Hill, Allergic Living, and the Washington Times, CLEAR’s leadership was widely reported on during CLEAR’s inaugural briefing in the U.S. Senate on November 21, 2019. Moderated by Founder Robert Houton, panelists included in-flight anaphylactic attack survivor and Harvard University student Alexa Jordan; Dr. Jonathan Spergel, Director of the World Allergy Center and Chief of Allergy at Children’s Hospital of Philadelphia; Dr Paulo Alves, Global Medical Director, Aviation Health, Medaire; and Lianne Mandlebaum, Founder, No Nut Traveler, elected officials, and first responders among others as leading in fulfilling our mission. Included among these activities are working with our Members to communicate CLEAR’s unified advocacy with federal, state, and local legislators to support policies and programs which increase access to emergency medicines including, but not limited to, epinephrine for anaphylaxis and naloxone hydrochloride for drug overdose.

 

LATEST PRESS

STAY

CONNECTED

CONTACT US

Ready to learn more about CLEAR and our lifesaving initiatives? Contact us today for more information.

contact@clearsaves.com

Fill out this field
Fill out this field
Fill out this field
Menu